Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical primitive neuroectodermal tumor.

A S Tsao1, L M Roth, A Sandler

  • 1Department of Internal Medicine, Indiana University, Indianapolis, Indiana 46202-5427, USA.

Gynecologic Oncology
|October 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials.

Clinical radiology·2020
Same author

Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study.

European journal of cancer (Oxford, England : 1990)·2018
Same author

Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.

British journal of cancer·2011
Same author

Vascular injury following accidental intra-arterial injection of clindamycin: adverse drug reaction report.

Minerva anestesiologica·2011
Same author

The clinical picture of papataci fever, especially in Palestine.

The Medical journal of Australia·2010
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

This case report details a rare cervical primitive neuroectodermal tumor (PNET) in a pregnant patient. Early diagnosis and multimodal treatment led to a successful outcome, highlighting PNET

Area of Science:

  • Gynecologic Oncology
  • Neuro-oncology
  • Rare Cancers

Background:

  • Primitive neuroectodermal tumors (PNETs) are uncommon and aggressive malignancies.
  • Cervical PNET is distinct from uterine PNET, affecting younger women.
  • PNETs can present as cervical masses, even during pregnancy.

Observation:

  • A 24-year-old pregnant woman presented with a cervical mass.
  • Biopsy revealed poorly differentiated carcinosarcoma with neuroendocrine features, confirmed as PNET via immunohistochemistry.
  • The patient was treated with chemotherapy (cyclophosphamide, adriamycin, vincristine, ifosfamide, etoposide) and radiotherapy, alongside radical hysterectomy and ovarian transposition.

Findings:

  • The patient achieved a disease-free status 2 years post-treatment.

Related Experiment Videos

  • Cervical PNET in pregnancy is rare but manageable with timely intervention.
  • This case supports the distinction between cervical and uterine PNETs, suggesting a different histogenesis.

    • Implications:

    • Pregnancy should not impede the prompt diagnosis of cervical PNET.
    • Multimodal treatment approaches are effective for managing this rare malignancy.
    • Further research into the histogenesis and optimal management of cervical PNET is warranted.